The GG rs292001 genotype prevails in seronegative for ANA and anti-dsDNA antibodies patients with lupus nephritis

Maria Atanasova Radanova; Kamelia Bratoeva; Neshe Nazifova-Tasinova; Miglena Todorova; Vasil Vasilev; Diana Ivanova

doi:10.14748/ssm.v48i3.1727

The GG rs292001 genotype prevails in seronegative for ANA and anti-dsDNA antibodies patients with lupus nephritis

Maria Atanasova Radanova, Kamelia Bratoeva, Neshe Nazifova-Tasinova, Miglena Todorova, Vasil Vasilev, Diana Ivanova

Abstract

Rs292001 is single nucleotide polymorphism in non-coding regions of C1QA gene. C1q is subcomponent of the C1 first component of the classical pathway of complement activation. Rs292001 was investigated for association with some conventional immunological markers of lupus nephritis activity in SLE patients - levels of C1q, C3, C4, anti-C1q, anti-nuclear (ANA) and anti-dsDNA autoantibodies.Genomic DNA was isolated from peripheral blood of 18 patients with biopsy-proven lupus nephritis (LN). SNP genotyping for the presence of rs292001 was performed by quantitive real-time PCR method. Presence of complement C1q, C3 and C4 and anti-C1q autoantibodies was screened by ELISA. ANA and anti-dsDNA antibodies were detected by indirect immunofluorescence.We found that GG rs292001 genotype prevailed in seronegative for ANA and anti-dsDNA antibodies LN patients (p=0.008; p<0.012). The AA rs292001 genotype showed a trend towards lower serum C1q levels.These results reaffirm a previously established probable protective role of G allele against the clinical activity of the SLE.

Keywords

rs292001, ANA, anti-dsDNA Abs, C1q, Lupus nephritis

Full Text

References

Racila DM, Sontheimer C, Sheffield A, Wisnieski JJ, Racila E, Sontheimer RD. Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 2003;12(2):124-32.

Chew CH, Chua KH, Lian LH, Puah SM, Tan SY. PCR–RFLP genotyping of C1q mutations and single nucleotide polymorphisms in Malaysian patients with systemic lupus erythematosus. Hum Biol. 2008;80(1):83-93.

Martens HA, Zuurman MW, de Lange AH, Nolte IM, van der Steege G, Navis GJ, et al. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity. Ann Rheum Dis. 2009;68(5):715-20.

Namjou B, Gray-McGuire C, Sestak AL, Gilkeson GS, Jacob CO, Merrill JT, et al. Evaluation of C1q genomic region in minority racial groups of lupus. Genes Immun. 2009;10(5):517-24.

Rafiq S, Frayling TM, Vyse TJ, Cunninghame Graham DS, Eggleton P. Assessing association of common variation in the C1Q gene cluster with systemic lupus erythematosus. Clin Exp Immunol. 2010;161(2):284-9.

Zervou MI, Vazgiourakis VM, Yilmaz N, Kontaki E, Trouw LA, Toes RE, et al. TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey. Hum Immunol. 2011;72(12):1210-3.

Cao CW, Li P, Luan HX, Chen W, Li CH, Hu CJ, et al. Association study of C1qA polymorphisms with systemic lupus erythematosus in a Han population. Lupus 2012;21(5):502-7.

Devaraju P, Reni BN, Gulati R, Mehra S, Negi VS. Complement C1q and C2 polymorphisms are not risk factors for SLE in Indian Tamils. Immunobiology 2014;219(6):465-8.

Radanova M, Vasilev V, Dimitrov T, Deliyska B, Ikonomov V, Ivanova D. Association of rs172378 C1q gene cluster polymorphism with lupus nephritis in Bulgarian patients. Lupus, 2015;24(3):280-9.

Mosaad YM, Hammad A, Fawzy Z, El-Refaaey A, Tawhid Z, Hammad EM, et al. C1q rs292001 polymorphism and C1q antibodies in juvenile lupus and their relation to lupus nephritis. Clin Exp Immunol. 2015;182(1):23-34.

- Radanova M, Tsacheva I, Argirova T, Kojuharova M. Interaction of recombinant globular head regions of C1q with normal and autoimmune sera. Annulare de I`Universite de Sofia “St. Kliment Ohridski”, Faculte de biologie, 2005;96(4):17-24.

Tsacheva I, Radanova M, Todorova N, Argirova T, Kishore U. Detection of autoantibodies against the globular domain of human C1q in the sera of systemic lupus erythematosus patients. Mol Immunol. 2007;44(8):2147-51.

Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol. 2003;24:(11):595-602.

Korczowska I, Trzybulska D, Ostanek L, Brzosko M, RosiÅ„ska M, Niemir Z, et al. Polymorphism of C1q complement (rs292001) occurrence in systemic lupus erythematosus patients. Borgis Prog Med Sci. 2012;12:981-5.

Meroni PL, Shoenfeld Y. Systemic lupus erythematosus and the SLE galaxy. Autoimmun Rev 2010;10(1):1-2.

Trouw LA, Daha N, Kurreeman FA, Böhringer S, Goulielmos GN, Westra HJ, et al. Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis. Clin Exp Immunol. 2013;173(1):76-83.

Goulielmos GN, Samonis G, Apergi M, Christofaki M, Valachis A, Zervou MI, et al. C1q but not mannose-binding lectin (Mbl-2) gene polymorphisms are associated with type 2 diabetes in the genetically homogeneous population of the island of Crete in Greece. Hum Immunol. 2013;74(7):878-81.

Mosaad YM, Al-Harrass M, El-Basyouni SR, Hammad EM, Fawzy IM, Abdelgawad MS. C1q rs292001 polymorphism association with Rheumatoid arthritis and BehÃ§et's disease. Inter J Adv Res. 2015;3(8):1255-66.

Zakharyan R, Khoyetsyan A, Arakelyan A, Boyajyan A, Gevorgyan A, Stahelova A, et al. Association of C1QB gene polymorphism with schizophrenia in Armenian population. BMC Med Genet. 2011;12:126.

DOI: http://dx.doi.org/10.14748/ssm.v48i3.1727

Array

SUBMIT

User Guide